Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)

被引:8
作者
Kuniholm, Mark H. [1 ]
Jung, Molly [1 ]
Del Amo, Julia [2 ]
Talavera, Gregory A. [3 ]
Thyagarajan, Bharat [4 ]
Hershow, Ronald C. [5 ]
Damas, Oriana M. [6 ]
Kaplan, Robert C. [1 ]
机构
[1] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Belfer Bldg,Room 1308,1300 Morris Pk Ave, Bronx, NY 10461 USA
[2] Inst Salud Carlos III, Natl Ctr Epidemiol, Madrid, Spain
[3] San Diego State Univ, Grad Sch Publ Hlth, Inst Behav & Community Hlth, San Diego, CA 92182 USA
[4] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA
[5] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA
[6] Univ Miami, Miller Sch Med, Dept Med, Div Gastroenterol, Miami, FL 33136 USA
关键词
Hepatitis C virus; Hispanic; Latino; United States; Awareness; PEGYLATED INTERFERON; GENOTYPE; SERVICES; RIBAVIRIN; DESIGN; COHORT;
D O I
10.1007/s10903-016-0350-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Few population-based studies have assessed awareness of hepatitis C virus (HCV) seropositivity and chronic infection. We report awareness of HCV seropositivity and chronic infection and correlates of awareness in a multi-city (Bronx, Miami, Chicago, and San Diego) community-dwelling population sample of United States (US) Hispanics/Latinos recruited during 2008-2011. Included were 260 HCV-seropositive participants, among whom 190 had chronic HCV. Among those with chronic HCV, 46 % had been told by a doctor that they had liver disease and 32 % had been told that they had HCV-related liver disease. Among those with chronic HCV who also lacked health insurance (37 % of those with chronic HCV), only 8 % had been told that they had HCV-related liver disease. As compared with the uninsured, those with insurance were over five times more likely to be aware of having HCV-related liver disease (44 %). Sex, age, education, city of residence, and birthplace were not associated with HCV awareness. Less than half of Hispanics/Latinos were aware of their HCV chronic infection. Lack of health insurance may be an important barrier to HCV awareness in this population.
引用
收藏
页码:1257 / 1265
页数:9
相关论文
共 18 条
  • [1] Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
    Adinolfi, LE
    Gambardella, M
    Andreana, A
    Tripodi, MF
    Utili, R
    Ruggiero, G
    [J]. HEPATOLOGY, 2001, 33 (06) : 1358 - 1364
  • [2] Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008
    Denniston, Maxine M.
    Klevens, R. Monina
    McQuillan, Geraldine M.
    Jiles, Ruth B.
    [J]. HEPATOLOGY, 2012, 55 (06) : 1652 - 1661
  • [3] Effectiveness of Hepatitis C Treatment with Pegylated Interferon and Ribavirin in Urban Minority Patients
    Feuerstadt, Paul
    Bunim, Ari L.
    Garcia, Heriberto
    Karlitz, Jordan J.
    Massoumi, Hatef
    Thosani, Amar J.
    Pellecchia, Andrew
    Wolkoff, Allan W.
    Gaglio, Paul J.
    Reinus, John F.
    [J]. HEPATOLOGY, 2010, 51 (04) : 1137 - 1143
  • [4] Body Mass Index, Sex, and Cardiovascular Disease Risk Factors Among Hispanic/Latino Adults: Hispanic Community Health Study/Study of Latinos
    Kaplan, Robert C.
    Aviles-Santa, Larissa
    Parrinello, Christina M.
    Hanna, David B.
    Jung, Molly
    Castaneda, Sheila F.
    Hankinson, Arlene L.
    Isasi, Carmen R.
    Birnbaum-Weitzman, Orit
    Kim, Ryung S.
    Daviglus, Martha L.
    Talavera, Gregory A.
    Schneiderman, Neil
    Cai, Jianwen
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (04):
  • [5] Prevalence of Hepatitis C Virus Infection in US Hispanic/Latino Adults: Results From the NHANES 2007-2010 and HCHS/SOL Studies
    Kuniholm, Mark H.
    Jung, Molly
    Everhart, James E.
    Cotler, Scott
    Heiss, Gerardo
    McQuillan, Geraldine
    Kim, Ryung S.
    Strickler, Howard D.
    Thyagarajan, Bharat
    Youngblood, Marston
    Kaplan, Robert C.
    Ho, Gloria Y. F.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (10) : 1585 - 1590
  • [6] Sample Design and Cohort Selection in the Hispanic Community Health Study/Study of Latinos
    Lavange, Lisa M.
    Kalsbeek, William D.
    Sorlie, Paul D.
    Aviles-Santa, Larissa M.
    Kaplan, Robert C.
    Barnhart, Janice
    Liu, Kiang
    Giachello, Aida
    Lee, David J.
    Ryan, John
    Criqui, Michael H.
    Elder, John P.
    [J]. ANNALS OF EPIDEMIOLOGY, 2010, 20 (08) : 642 - 649
  • [7] Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
    Lawitz, Eric
    Sulkowski, Mark S.
    Ghalib, Reem
    Rodriguez-Torres, Maribel
    Younossi, Zobair M.
    Corregidor, Ana
    DeJesus, Edwin
    Pearlman, Brian
    Rabinovitz, Mordechai
    Gitlin, Norman
    Lim, Joseph K.
    Pockros, Paul J.
    Scott, John D.
    Fevery, Bart
    Lambrecht, Tom
    Ouwerkerk-Mahadevan, Sivi
    Callewaert, Katleen
    Symonds, William T.
    Picchio, Gaston
    Lindsay, Karen L.
    Beumont, Maria
    Jacobson, Ira M.
    [J]. LANCET, 2014, 384 (9956) : 1756 - 1765
  • [8] The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
    Lo Iacono, O.
    Venezia, G.
    Petta, S.
    Mineo, C.
    De Lisi, S.
    Di Marco, V.
    Rodolico, V.
    Amato, M.
    Ferraro, D.
    Giordano, C.
    Almasio, P. L.
    Craxi, A.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 25 (10) : 1181 - 1191
  • [9] HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN
    MATTHEWS, DR
    HOSKER, JP
    RUDENSKI, AS
    NAYLOR, BA
    TREACHER, DF
    TURNER, RC
    [J]. DIABETOLOGIA, 1985, 28 (07) : 412 - 419
  • [10] Estimating the relative risk in cohort studies and clinical trials of common outcomes
    McNutt, LA
    Wu, CT
    Xue, XN
    Hafner, JP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 157 (10) : 940 - 943